A recent Phase II trial from CMC Vellore, NeoLOCUS, might have just challenged one of the most entrenched practices in head and neck oncology. We are moving from chemotherapy to biology-driven cancer treatment. And that shift has already begun in India. Rethinking Neoadjuvant Strategy: The NeoLOCUS Approach The NeoLOCUS trial explored a simple but
1448 Reached8 Comments
Complicated case of Osteoarthritis
1850 Reached2 Comments3 Likes
CT Angiography of Spontaneous Coronary Artery Dissection
4208 Reached15 Comments13 Likes
Cardiac Amyloidosis Mimicking Severe Aortic Valve Stenosis
6688 Reached15 Comments15 Likes
Case of Increased Risk of Pregnancy-associated Breast Cancer Recurrence
1008 Reached2 Comments
Treatment of Recurrent Adult Medulloblastoma
2602 Reached1 Comments4 Likes